8-K/A: Current report filing
Published on March 28, 2024
听
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
听
FORM 8-K/A
听
CURRENT REPORT
Pursuant to Section听13 or 15(d) of the Securities Exchange Act of 1934
听
Date of Report (Date of earliest event reported): March 28, 2024
听
(Exact Name of Registrant as Specified in its Charter)
听
|
|
听 |
|
听 |
|
|
(State or Other Jurisdiction
of Incorporation)
|
听 |
(Commission
File Number)
|
听 |
(IRS Employer
Identification No.)
|
听
|
|
|
|
听 |
|
|
(Address of Principal Executive Offices)
|
听 |
(Zip Code)
|
||
Registrant鈥檚 telephone number, including area code: (305 )听575-4100
听
|
Not Applicable
|
|
Former name or former address, if changed since last report
|
听
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
听
听
听
听
听
Securities registered pursuant to Section 12(b) of the Act:
听
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
听
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (搂230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (搂240.12b-2 of this chapter).
听
Emerging growth company听听听听听听听听听鈽� 听听听听听听听听听
听
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.听听听听听听听听听听听听听听听听听听鈽�
听
听
听
听
听
EXPLANATORY NOTE
听
This filing amends Item 9.01 of the Current Report on Form 8-K filed March 28, 2024 by 男人宫殿. (the 鈥淥PKO鈥�), and specifically Exhibit 99.1, Investor Presentation, to replace the previously used January presentation with OPKO鈥檚 updated presentation.
听
听
|
ITEM 9.01.
|
Financial Statements and Exhibits.
|
听
| 听 |
(d)
|
Exhibits
|
听
|
Exhibit听
No.
|
听 | Description |
| 听 | 听 | 听 |
| 2.1* | 听 | Asset Purchase Agreement, dated as of March 27, 2024 by and among BioReference Health, LLC, 男人宫殿. and Laboratory Corporation of America Holdings |
| 99.1 | 听 | Investor Presentation, dated March 27, 2024 |
| 104 | 听 | Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document |
听
*听听 Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar attachments to this exhibit have been omitted because they do not contain information material to an investment or voting decision and such information is not otherwise disclosed in such exhibit. The Company will supplementally provide a copy of any omitted schedule or similar attachment to the U.S. Securities and Exchange Commission or its staff upon request.
听
听
听
听
SIGNATURES
听
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
听
| 听 | 听 |
男人宫殿.
|
|
| 听 | 听 | 听 | 听 |
| 听 | 听 |
By:
|
/s/ Steven D. Rubin
|
|
Date: March 28, 2024
|
听 |
Name:
|
Steven D. Rubin
|
| 听 | 听 |
Title:
|
Executive Vice President-Administration
|
| 听 | 听 | 听 | 听 |
听
听